Zhao, Yawei
He, Meihui
Cui, Lianzhi
Gao, Mohan
Zhang, Min
Yue, Fengli
Shi, Tongfei
Yang, Xuehan
Pan, Yue
Zheng, Xiao
Jia, Yong
Shao, Dan
Li, Jing
He, Kan
Chen, Li
Article History
Received: 2 October 2019
Revised: 18 January 2020
Accepted: 10 March 2020
First Online: 3 April 2020
Ethics approval and consent to participate
: The collection of ovarian cancer tissue was approved by the Ethics Committee of Jilin Cancer Hospital and performed in accordance with the Declaration of Helsinki. All patients signed written informed consent before participating in this study. The SKOV-3 and A2780 cell lines were purchased from The Cell Bank of Chinese Academy of Sciences (Shanghai, China). The KURAMOCHI cell line was purchased from Japanese Collection of Research Bioresources (JCRB) Cell Bank.
: Not applicable.
: The datasets used and/or analysed during this study are available from the corresponding author on reasonable request. The RNA-seq dataset GSE109934 is available in the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/).<sup>27</sup> The survival analysis was performed using the PROGgeneV2 website tool (ExternalRef removed).<sup>28</sup>
: The authors declare no competing interests.
: This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.